Key result
Thrombolysis successfully manages a case of early thrombosis following a percutaneous tricuspid valve-in-valve procedure.
Why the study?
Bioprosthetic valve thrombosis is increasingly recognized with valve in valve procedures, but the optimal management strategy in the acute context is not established.
Does thrombolysis successfully manage early thrombosis following percutaneous tricuspid valve-in-valve implantation?
Case Report (n=1)
Does thrombolysis successfully manage early thrombosis following percutaneous tricuspid valve-in-valve implantation?
Thrombolysis may be a successful management strategy for early bioprosthetic valve thrombosis following percutaneous tricuspid valve-in-valve implantation.
Answers are grounded in this paper and cite their sources.
Thrombolysis may be viable for early thrombosis after tricuspid valve-in-valve; leaves open need for prospective data before wider adoption.
Bioprosthetic valve thrombosis is a growing recognized entity, especially with the increasing use of the valve in vale procedures and the advent of new detection technologies (e.g., 4D CT and 4D echocardiography). However, the optimal management strategy in the acute context is not established. This paper presents a case of early thrombosis following the percutaneous tricuspid valve in vale procedure that was successfully managed with thrombolysis.
No takes yet. Share an insight, caveat, or question.
Rahnamoun et al. (2022) conducted a case report in Early thrombosis following percutaneous tricuspid valve-in-valve implantation (n=1). Thrombolysis was evaluated on Successful management of early thrombosis. Thrombolysis successfully managed a case of early thrombosis following a percutaneous tricuspid valve-in-valve procedure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: